Our previous work reported that Scl1 selectively binds to cancer-associated fibroblast (CAF)-deposited oncofetal fibronectin (47, 48, 65), which can modulate the tumor extracellular matrix microenvironment (49). The gene discussed is FN1; the disease is cancer.